Royal Bank of Canada’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Royal Bank of Canada’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,321	Closed	-$27K	–	7846
2023 Q2	$27K	Buy	15,321 +13,321	+666%	+$17.6K	﹤0.01%	6067
2023 Q1	$3K	Hold	2,000	–	–	﹤0.01%	6730
2022 Q4	$6K	Sell	2,000 -71	-3%	-$279	﹤0.01%	6708
2022 Q3	$9K	Buy	2,071 +71	+4%	+$229	﹤0.01%	6496
2022 Q2	$8K	Hold	2,000	–	–	﹤0.01%	6491
2022 Q1	$8K	Sell	2,000 -8,000	-80%	-$29.8K	﹤0.01%	7078
2021 Q4	$47K	Buy	10,000 +8,000	+400%	+$56.8K	﹤0.01%	6405
2021 Q3	$14K	Buy	+2,000	New	+$18.9K	﹤0.01%	6854

Other funds holding MIRO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFP

Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Royal Bank of Canada's MIRO Position: Q3 2023 in Review

Royal Bank of Canada sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2023, closing a stake of 15,321 shares — an estimated $27K sold.

Royal Bank of Canada first reported a position in MIRO in Q3 2021 and held it in 8 quarters. The position peaked at $47K in Q4 2021. 32 funds tracked by Wall St. Rank hold MIRO as of Q3 2023.

Royal Bank of Canada reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 15,321 Miromatrix Medical Inc. Common Stock shares in Q3 2023, an estimated $27K.
Royal Bank of Canada first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Royal Bank of Canada's Miromatrix Medical Inc. Common Stock position peaked at $47K in Q4 2021.
32 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.